Medicine for treating liver cancer

Abstract

The invention relates to a medicine for treating liver cancer which is prepared from the following Chinese medicinal raw materials (by weight ratio): zedoary 35-45 parts, notoginseng 15-20 parts, bulb of edible tulip 35-45 parts, Eupolyphaga Sinensis Walker 5-10 parts, pangolin scales 20-30 parts, rheum officinale 20-30 parts, astragalus root 35-45 parts, fleece-flower root 35-45 parts and Chinese angelica root 20-30 parts.

Description

technical field

[0001] The invention relates to a medicine for treating liver cancer, which belongs to the field of medicine. Background technique

[0002] Primary liver cancer refers to the tumor of liver cells or intrahepatic bile duct cells. It is a highly malignant type of cancer. Clinically, it is characterized by progressive enlargement of the liver and pain, jaundice, fever, ascites, hemorrhage, nail Positive fetoprotein is the main manifestation. This disease is more common in China. The incidence rate is higher in East China and South China. The incidence rate in Asia and Africa is significantly higher than other regions in the world. The age of ~50 is more, and the male to female ratio is 4 to 7:1. Because the disease develops rapidly, the condition is complicated, and the treatment effect is poor, it is extremely harmful to the health of the people.

[0003] At present, there is no effective method for the treatment of liver cancer. Most of them are surgery and p...